Registration and Continental Breakfast
Welcome and Opening Remarks
Keynote Address: Demanding Quality in the Health Care System, David B. Nash, MD, MBA, Thomas Jefferson University , ACPE #0012-9999-11-173-L04-P (K)
The goal of our country’s health care system is to prevent, diagnose, and treat disease and to improve the physical and mental well-being of all Americans. Across the lifespan, health care helps people stay healthy, recover from illness, live with chronic disease or disability, and cope with death and dying (AHRQ National Healthcare Quality Report, 2010).
Despite the fact that health care providers currently have access to more valid clinical evidence and more technology than ever before, there remains significant concern about deficiencies in quality of our present medical care delivery system. This presentation will address responses to these deficiencies that could transform the economics of our health care system—such as improving physician decision-making, promoting evidence-based practice and strengthening clinical information systems. Dr. Nash will show that in a Zen-like paradox, as doctors surrender some autonomy they gain greater professionalism and they promote transparency and accountability.
How Gaming Theory Empowers Engagement in Wellness Programs, Douglas Goldstein, eFuturist, ACPE #0012-9999-11-174-L04-P (K)
Gamification, the process of turning work into play, is growing exponentially. It has the potential to transform health care by delivering a new interface with consumers and patients that capitalizes on the strong existing trends of how people want to receive information while developing new life skills. This discussion will explain how gamification takes what is considered work and turns it into a fun engaging experience that builds healthier behaviors and skills in a more effective and engaging approach than other learning methods, specifically as it relates to informing engagement in wellness programs.
State-of-the-Art Management of Ovarian Cancer, Levi S. Downs, MS, MD, University of Minnesota Medical School, ACPE #0012-9999-11-175-L04-P (K)
Ovarian cancer is the fifth leading cause of cancer deaths in women. Because symptoms often do not occur until late in the disease, only about 20 percent of ovarian cancers are found at an early stage while there is the greatest chance of cure. Unfortunately, though there is no definitive screening test that can reliably lead to early diagnosis of this disease and a high rate of cure, choosing the optimal therapeutic intervention at the earliest possible stage is critical to extending progression-free survival and improving quality of life. In addition to providing an update on the screening, prevention, and treatment of this ovarian cancer, this presentation will address the critical importance of clinical expertise and optimal multimodality management in the treatment of complex cancers such as ovarian cancer.
Pharmacogenomics: Optimizing Drug Efficacy and Minimizing Toxicity, Peter H. O'Donnell, MD, The University of Chicago, ACPE #0012-9999-11-176-L04-P (K)
Pharmacogenomics refers to the development of novel drugs based upon the rapidly evolving knowledge of the genetic determinants that influence drug response. In theory, the identification of genetic factors that influence drug absorption, metabolism, and action at the receptor level should allow for individualized therapy, which could optimize drug efficacy and minimize toxicity. There is a huge potential for cost savings (through increased drug efficacy) and for decreasing morbidity and mortality (through increased drug safety and fewer adverse drug reactions [ADRs]).
This presentation will provide an overview of the field of pharmacogenomics, explain the different ways in which pharmacogenetic differences can affect the patient’s response to drug therapy, identify the challenges that must be overcome before routine pharmacogenetic testing (genotyping) is fully integrated into mainstream clinical medicine and address the cost effectiveness of this practice.
Support for this lunch is provided by CardioDx.
The COURAGE Trial: Encouraging Clinicians to Use the Most Effective, Evidence-Based and Patient-Appropriate Treatments, John Spertus, MD, MPH, FACC, FAHA, Mid America Heart Institute of Saint Luke¹s Hospital, ACPE #0012-9999-11-177-L04-P (K)
In 2007, the ground-breaking COURAGE Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial revealed that percutaneous coronary intervention (PCI) offered no incremental benefit over aggressive medical management when performed in patients with stable coronary artery disease, and suggested that PCI could be deferred in patients with stable disease as long as optimal medical therapy (OMT) was administered.
A recent study published in JAMA in June of this year examined the use of OMT in patients with stable angina undergoing PCI before and after the publication of the COURAGE trial. The article concluded: “Among patients with stable CAD undergoing PCI, less than half were receiving OMT before PCI and approximately two-thirds were receiving OMT at discharge following PCI, with relatively little change in these practice patterns after publication of the COURAGE trial.”
This presentation will address the clearly identified gap in cardiology practice revealed by the JAMA paper and will address the question “How do we encourage doctors and hospitals to use the most effective, evidence-based and patient-appropriate treatments, backed by clinical data and scientific studies?”
Current Management of Prostate Cancer: Assisting Consumers in Making Informed Decisions, James L. Mohler, MD, Roswell Park Cancer Institute, ACPE #0012-9999-11-178-L04-P (K)
Prostate cancer is the second leading cause of cancer deaths in men. Since clinical knowledge in the field of prostate cancer is rapidly changing and there is a variety of viable treatment options, ensuring consumers are provided with the right information that will allow them to make an informed decision on treatment (or no treatment) may be challenging. This presentation will review emerging clinical data on management options for prostate cancer and will discuss situations when active surveillance might be the best option. A summary of current approaches to the screening, diagnosis and treatment of clinically localized cancer of the prostate will be provided.
Health Literacy: The Importance of Effective Patient Communication, Michael Wolf, PhD, MPH, Northwestern University Feinberg School of Medicine, ACPE #0012-9999-11-179-L04-P (K)
Health literacy is defined as the degree to which individuals have the capacity to obtain, process, and understand basic information and services needed to make appropriate decisions regarding their health (Health People 2010). A report from the Institute of Medicine (IOM) entitled Health Literacy: A Prescription to End Confusion says that nearly half of all American adults—90 million people—have difficulty understanding and using health information. Among patients with limited health literacy, there is a higher rate of hospitalization and use of emergency services, indicating that limited health literacy may lead to billions of dollars in avoidable health care costs. In addition, according to the IOM 2006 report, Preventing Medication Errors, more than half a million adverse drug events that occur in the United States each year in outpatient settings are due in large part to problems with prescription drug (Rx) labeling. Though the ability to understand Rx container label instructions is critical, research has highlighted that an alarmingly high prevalence of patients misunderstand seemingly simple instructions and warnings placed on Rx container labels.
This presentation will address the current state of health literacy and discuss methods to facilitate patients’ comprehension of health information, particularly in relation to medication adherence, in an attempt to improve their quality of care and reduce health costs.
Integrating Technology into the Health Care System to Promote Healthy Lifestyles and Improve Health Care Outcomes, Mark Blatt, MD, MBA, Digital Health Group, Intel Corporation, ACPE #0012-9999-11-180-L04-P (K)
The communication capabilities and ease of information access of mobile devices have enormous potential as tools to revolutionize the way health care is delivered in the U.S. This session will discuss the use of mobile technologies to promote healthy lifestyle changes, encourage patients’ active involvement in their treatment, reduce waiting times in doctors’ offices, and improve a provider’s access to patient information, all with the goal of improving health care outcomes. The challenges and opportunities in using mobile technology as a conduit for information to connect individuals, patients, and care providers to promote good health and enhance well-being will be presented.
Reception and Exhibits
Support for this dinner is provided by UCB, Inc.